Abstract:The impact of COVID-19 on pregnant women and newborns continues to be a critical societal concern. However, the majority of research focuses on the disease resulting from the early pandemic variants, without sufficient study on the more recent BA.5.2/BF.7. We retrospectively recruited pregnant women giving birth during the surge of the BA.5.2/BF.7 and analysed the risk impact of COVID-19 on maternal and neonatal outcomes. Furthermore, subjects matched through propensity scores were used for the analysis of clinical laboratory tests. A total of 818 pregnant women were enrolled, among 276 (33.7%) were diagnosed with SARS-CoV-2 during childbirth. COVID-19 significantly increased the risk of a hospital length of stay equal to or greater than seven days and neonatal admission to the neonatal intensive care unit, with an aHR of 2.03 (95% CI, 1.22–3.38) and 1.51 (95% CI, 1.12–2.03), respectively. In the analysis of 462 matched subjects, it was found that subjects infected with SARS-CoV-2 tended slight leucopenia and coagulation abnormalities. We found that during the surge of the BA.5.2/BF.7, COVID-19 increased the risk of maternal and neonatal outcomes among Chinese pregnant women. This finding offers significant insights to guide clinical practices involving pregnant women infected with the recently emerged Omicron subvariants.

What problem does this paper attempt to address?

This paper aims to explore the health impacts of COVID - 19 on pregnant women and their newborns during the BA.5.2/BF.7 variant virus epidemic. Specifically, the researchers evaluated the impact of COVID - 19 infection on clinical outcomes such as maternal length of hospital stay and neonatal admission to the neonatal intensive care unit (NICU) by retrospectively analyzing the data of pregnant women who gave birth at the Women and Children's Hospital Affiliated to Xiamen University in China from the end of 2022 to the beginning of 2023. In addition, the differences in clinical laboratory test results between pregnant women infected with SARS - CoV - 2 and those not infected were analyzed by the propensity score - matching method. The main objectives of the study are: 1. To evaluate the health impacts of COVID - 19 infection on pregnant women and newborns, especially during the BA.5.2/BF.7 variant virus period. 2. To analyze the specific changes in clinical laboratory tests of pregnant women infected with SARS - CoV - 2, including blood routine, coagulation function, and metabolic indicators. The study found that non - severe COVID - 19 significantly increased the risk of pregnant women staying in the hospital for more than 7 days (adjusted hazard ratio aHR = 2.03, 95% confidence interval 1.22 - 3.38), and the risk of neonatal admission to the NICU (aHR = 1.51, 95% confidence interval 1.12 - 2.03). However, no significant impacts were observed on other adverse outcomes such as stillbirth, low Apgar score, premature birth, and miscarriage. These results provide an important reference for how to better manage and protect pregnant women infected with COVID - 19 in clinical practice.

Maternal and neonatal outcomes and clinical laboratory testing of pregnant women with COVID-19 during the BA.5.2/BF.7 surge